The FDA has approved Pfizer’s marstacimab under the brand name Hympavzi for adults and children with hemophilia A or B, ...

Now that his sons are grown, columnist Joe MacDonald struggles with letting go of the past and moving on from his role as a caregiver.

MacDonald talks with her 18-year-old son, Caeleb, about how chronic pain affects his life and perception of color.

Beqvez (fidanacogene elaparvovec) led to about three times fewer bleeding episodes than preventive treatment with regular ...

Some risks are worth taking, even in a life with hemophilia, columnist Alliah Czarielle has found. In fact, they can be good for us.

We must weather the biggest of storms together and harness the power of community when life is hard, columnist Jennifer Lynne writes.

Data showed 85% of people diagnosed with acquired hemophilia A had a positive response to immunotherapy combined with ...

Columnist Joe MacDonald, after attending the recent annual conference of the National Bleeding Disorders Foundation, noted three takeaways.